Podcasts about Femtech

What does it really take to thrive as a first-time fund manager in today's challenging investment landscape, especially when you're building a venture fund from scratch while championing diversity and innovation? This episode delves into the real experiences behind the headlines, inviting listeners to consider the often unseen hurdles and triumphs that define entrepreneurial journeys. Our guest, Laurel Mintz, is the founder of Fabric VC—a new venture capital fund spun out of her extensive 17-year run as the leader of a successful marketing agency. With a background that includes corporate M&A law, entrepreneurship, and marketing, Laurel Mintz brings a unique and practical perspective to the venture capital world. Her approach blends deep sector knowledge with a commitment to supporting underrepresented founders and championing women's health, fintech, and consumer tech sectors. In this update, listeners get an inside look at the nuts and bolts of raising and deploying Fabric VC's first fund—just under $8 million, already largely deployed across 23 portfolio companies. Laurel Mintz shares candid insights on the emotional rollercoaster of fundraising, the critical importance of diversity, and the creative approaches to supporting women-led companies, such as accepting investments via donor-advised funds and retirement accounts. This episode is a must-listen for aspiring investors, founders, or anyone interested in how real change is being made within venture capital. It's raw, motivating, and packed with unfiltered advice on how to show up, take risks, and put capital to work for the next generation.   To get the latest from Laurel Mintz, you can follow her below! LinkedIn - https://www.linkedin.com/in/laurel-mintz/ https://www.fabricvc.com/ Laurel's first appearance on The Angel Next Door    Sign up for Marcia's newsletter to receive tips and the latest on Angel Investing! Website: www.marciadawood.com Learn more about the documentary Show Her the Money: www.showherthemoneymovie.com And don't forget to follow us wherever you are! Apple Podcasts: https://pod.link/1586445642.apple Spotify: https://pod.link/1586445642.spotify LinkedIn: https://www.linkedin.com/company/angel-next-door-podcast/ Instagram: https://www.instagram.com/theangelnextdoorpodcast/ TikTok: https://www.tiktok.com/@marciadawood

What happens when you know something is wrong with your body, but no one seems to be listening? In this episode, Stephanie Mitton sits down with award-winning journalist and host of TVO's Mistreated, Nam Kiwanuka, for a powerful conversation about women's health, medical dismissal, and the gaps in research that continue to impact women across Canada and beyond. Nam shares her personal experience navigating fibroids, chronic anemia, lengthy surgical wait times, and the frustration of advocating for care while trying to show up for her family and career. Together, they explore why women's health has been historically under-researched, how lived experience and evidence can work together, and what women can do to advocate for themselves in a complex health care system. This Episode Covers: Nam's personal health journey and the diagnosis that changed everything Why women are often dismissed or misdiagnosed in health care settings The impact of research gaps on conditions like fibroids, endometriosis, ADHD, migraines, and autoimmune diseases How social media can both help and hinder women searching for health information The importance of self-advocacy and knowing your medical history What femtech is and how innovation is helping address women's health challenges Practical ways women can support change in research, policy, and health care Women's health affects every aspect of our lives, from our careers and families to our confidence and wellbeing. This conversation is a reminder that your symptoms matter, your experiences matter, and your voice matters. Whether you're navigating your own health journey or supporting someone you love, you'll leave this episode with greater understanding and practical ways to advocate for better care. https://www.patreon.com/womendontdothat Instagram - http://www.instagram.com/womendontdothat/ TikTok- http://www.tiktok.com/@womendontdothat Blog- https://www.womendontdothat.com/blog Podcast- https://www.womendontdothat.com/podcast Newsletter- https://www.beaconnorthstrategies.com/contactwww.womendontdothat.com YouTube - http://www.youtube.com/@WOMENdontDOthat How to find Stephanie Mitton: Twitter/X- https://twitter.com/StephanieMitton LinkedIn - https://www.linkedin.com/in/stephaniemitton/ beaconnorthstrategies.com TikTok- https://www.tiktok.com/@stephmitton Instagram- https://www.instagram.com/stephaniemitton/ Interested in sponsorship? Contact us at hello@womendontdothat.com Produced by Duke & Castle Our Latest Blog: https://www.womendontdothat.com/post/i-don-t-do-resolutions-i-do-this-perfect-for-busy-women Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

MyCelsius are launching in Ireland but despite being based in Bristol, boss Aonghus has really strong Cork connections See also mycelsius.com Hosted on Acast. See acast.com/privacy for more information.

This special live episode of the FemTech Focus was recorded at the Johns Hopkins Bloomberg School of Public Health as part of a women's health innovation event.This panel explores what it actually takes to build in women's health—from identifying unmet clinical needs to navigating customer discovery, commercialization, regulation, fundraising, and equity in femtech innovation.The discussion features four innovators building next-generation solutions across pelvic health, menstrual health, fetal surgery, and digital maternal health.Moderator: Dr. Rosemary Morgan - Associate Professor, Department of International Health Johns Hopkins Bloomberg School of Public HealthDr. Morgan's work focuses on understanding how gender inequities shape health systems, healthcare access, and public health interventions globally. Her research spans sexual and reproductive health, gender analysis, and equity-centered global health systems research.

The Mira Hormone Monitor is a part of a growing Femtech movement designed to make reproductive hormone data available to women in an at-home setting. It promises a lot, but it's not cheap, so many women have some questions before they're ready to buy: How does Mira work? What will it require of the user? What kind of data does it actually provide? Does it work for every cycle type and every reproductive intention? Can it confirm ovulation? How? Can it be used with fertility awareness methods? To answer these questions and more, Caitlin invited Rose Mackenzie, Clinical Manager at Mira and FABM coach to talk about Mira and offer some special promotions to our listeners. Why special promotions? Because Mira is one of our sponsors for the upcoming book promotion of Caitlin's new book: Woven Well: A Christian Woman's Guide to Reproductive Health, Fertility, and Wholeness. More info below! NOTE: This episode is appropriate for all audiences.GUEST BIO: As the Clinical Manager at Mira, Rose assists healthcare professionals and providers in successfully using Mira with their patients. With over 10 years of experience as a natural family planning instructor trained in the Marquette Method and Sympto-Thermal Method, Rose has extensive experience assisting women using the Mira monitor for hormone monitoring and health promotion including women tracking their hormones in regular cycles, irregular cycles, postpartum amenorrhea, perimenopause, and chemo-induced menopause.SHOW NOTES:ALL pre-orders for Woven Well: A Christian Women's Guide to Reproductive Health, Fertility, and Wholeness are entered to win a Mira Hormone Monitor and Ultra4 Wand Kit! (Value of $250+) What does this mean for you? See below.#1. Pre-order the book here or here or your favorite book retailer. #2. Upload your receipt info here. Congrats! You're entered to win!* Want to order a Mira now? *Remember: Clients of Woven Natural Fertility Care receive a discount! Reach out to Caitlin for the code!Send Us a Text!Support the showOther great ways to connect with Woven Natural Fertility Care: Learn the Creighton Model System with us! Register here!Get our monthly newsletter: Get the updates!Chat about issues of fertility + faith: Substack Follow us on Instagram: @wovenfertilityWatch our episodes on YouTube: @wovenfertilityLove the content? The biggest gift you could give is to click a 5 star review and write why it was so meaningful! This podcast is provided for educational and informational purposes only and does not constitute providing medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. Neither Woven nor its staff, nor any contributor to this podcast, makes any representations, exp...

Women's health has been one of medicine's most overlooked frontiers — and the data gap is decades deep. In this episode, Eric Malzone sits down with Anaelle Oiknine, clinical development lead at Ultrahuman, to unpack why the majority of drugs, exercise prescriptions, and health metrics have historically been built around male physiology — and what that's cost women. From the thalidomide tragedy of the 1950s to the ongoing research mismatch around endometriosis, Anaelle breaks down the systemic failures that left half the population underserved, and why the tide is finally turning. She shares what continuous wearable data is revealing about the female body that annual OB-GYN visits never could — including how Ultrahuman's cycle and ovulation tracking has flagged PCOS and endometriosis before a physician's diagnosis. If you're a fitness professional, wellness practitioner, or just someone who wants to understand why cycle-based training is the next major evolution in personalized health, this conversation is where you start. Key Takeaways:

Belle and James from SomX chat through all the best news from this week.Stories:Palantir's NHS break clause is suddenly very much on the tableOpenAI launches ChatGPT for Clinicians, a free AI tool for physicians, NPs and pharmacistsThe Women's Health Strategy arrived with a £1.5m FemTech fund and a very quotable Streeting line

In this episode, Therese Markow and Dr. Chelsea Polis discuss the evolution of reproductive rights in the U.S., highlighting the 2022 Supreme Court decision revoking the right to abortion and the historical context of contraception access. Dr. Polis also explains fertility awareness-based methods (FABMs) and their effectiveness, noting that some methods have moderate quality studies suggesting high effectiveness, while others are less reliable. She emphasizes the importance of evidence-based information, the need for stronger regulation of femtech products, and the potential privacy risks associated with reproductive health data. Dr. Polis also addresses the broader political strategy to limit reproductive rights and the importance of reproductive justice.    Key Takeaways: Fertility tracking technologies are becoming more common (often called femtech), but it is important to note that only two apps have currently been cleared by the FDA for contraceptive purposes - Natural Cycles and Clue (the second is not currently available on the market). While others can help with tracking your cycle, they are not cleared for contraceptive use. FABMs focus on observing real-time signs from the body - such as cervical mucus changes and basal body temperature. Over a dozen have been studied in clinical trials, but some methods have been marketed or promoted for contraceptive use without strong evidence from appropriately designed effectiveness studies. For people who are in a partnership that is limited in terms of communication, or not supportive, or certainly abusive, or anything along those lines, FABMs would not be a method that somebody could rely on for pregnancy prevention.  Be very cautious about getting your information on contraception from social media influencers or companies selling specific products, because there is a lot of misinformation out there.   "As my colleagues at Guttmacher have documented, you can't seek to restrict one aspect of sexual and reproductive health without tightening other types of care and people's overarching reproductive freedoms. All of these things are deeply interconnected." —  Dr. Chelsea Polis   Episode References:  Guttmacher: https://www.guttmacher.org/united-states/contraception  Emergence of FemTech in the Sexual and Reproductive Health Landscape: https://www.contraceptionjournal.org/content/femtech    Connect with Dr. Chelsea Polis: Professional Bio: https://www.guttmacher.org/about/staff/chelsea-polis  Website: https://www.chelseapolis.com/index.html  LinkedIn: linkedin.com/in/chelseapolis  Bluesky: https://bsky.app/profile/cbpolis.bsky.social    Connect with Therese: Website:  www.criticallyspeaking.net Bluesky: @CriticallySpeaking.bsky.social Instagram: @criticallyspeakingpodcast Email: theresemarkow@criticallyspeaking.net   Audio production by Turnkey Podcast Productions. You're the expert. Your podcast will prove it.  

Winners will receive technical support to build a minimum viable product (MVP), worth up to €100,000, and gain access to investors Portugal will host a first-of-its-kind competition for femtech startups and research labs this spring. It will bring together innovators working at the intersection of artificial intelligence and women's health. The initiative, launched by the scientific platform EmbryoNet-AI in partnership with FemTech Real Money Talks Media, a European media platform covering innovation in women's health and femtech, aims to accelerate real-world breakthroughs by transforming early-stage ideas and clinical questions into working AI solutions. FemTech startups event in Portugal this spring "Women's health has been long underfunded, and under-researched. With this competition we want to change that and bring light to talented teams that are moving this field forward", Elena Lipilina, co-founder and CMO of Embryonet AI. Organizers have already launched an open call, which will remain open until 28 April 2026, with all submissions due by midnight CET. It is open for both Portuguese and international teams who have a strong hypothesis and access to imaging or time-series data, and who are seeking to answer critical questions in women's health using AI, whether in drug discovery, diagnostic support, or clinical research. Early-stage startups in women's health that do not yet have a product or MVP are also invited to apply. "We are interested in clinical and drug discovery challenges where AI has the potential to create a meaningful impact in women's health. This includes projects that leverage time-series phenotyping to better understand drug response and disease mechanisms in areas such as gynaecological cancers, endometriosis, and fertility research. We also interested in team that want to accelerate medical image pre-labeling for datasets derived from mammography, pelvic MRI, ultrasound, or pathology slides, as well as solutions that combine phenotypic and clinical data to support decision-making in clinical trials, biomarker discovery, and treatment stratification", shared Lipilina. Among applications, organizers will select up to 10 companies based on their potential impact on women's health, readiness of data, alignment with EmbryoNet-AI's capabilities, feasibility within the program timeframe, and the strength of their business case, alongside ethical and sustainability considerations. These shortlisted teams will move into the next phase—the Mentor Sprint, that will take place in early May 2026. During this period, participants will work closely with experts across technology, marketing, and clinical domains to refine their project scope and strengthen their approach. The program will culminate in a Live Pitch Day in May 2026, where finalists will present their solutions to a panel of investors and experts from the fields of women's health, artificial intelligence, and biotech. The winning team will then enter an 8–10 week build period, running from May to July 2026, during which EmbryoNet-AI will deliver a fully developed, services-first pilot at no cost. According to Lipilina, this will allow the team to save between €65,000 and €100,000—the typical cost of developing an MVP, depending on the product's complexity. The winner will also gain direct access to investors active in women's health and AI-driven biotech, as well as enhanced public credibility through investor-ready materials, including pitch decks, and media exposure. See more breaking stories here. More about Irish Tech News Irish Tech News are Ireland's No. 1 Online Tech Publication and often Ireland's No.1 Tech Podcast too. You can find hundreds of fantastic previous episodes and subscribe using whatever platform you like via our Anchor.fm page here: https://anchor.fm/irish-tech-news If you'd like to be featured in an upcoming Podcast email us at Simon@IrishTechNews.ie now to discuss. Irish Tech News have a range of services available to help p...

In this episode we dive into how women's sexual health, pleasure, and empowerment intersect with innovation in femtech. Carolyn Wheeler, CEO and co-founder of Vella Bioscience, shares her journey from landscape architecture to biotech leadership, advocating for evidence-based solutions and open conversations about female sexual wellness.How Carolyn Wheeler's background in architecture informs her approach to building companies and addressing gaps in women's health.The science behind female sexual arousal, why it remains an under-discussed and under-researched area, and the real physiological impacts of pleasure and orgasm.The innovation and technology behind Vella Bioscience's Women's Pleasure Serum, including the use of nanoencapsulated (liposome) delivery for increased efficacy.Challenges women face around libido, arousal, and societal stigma—especially related to antidepressant usage and hormonal changes.The importance of literacy, education, and agency in women's sexual health, plus practical book recommendations to explore further.TLDR:Female sexual wellness is a vital, transformative component of women's holistic health and leadership—yet it's historically under-researched and misunderstood. Through science-driven innovation, transparent conversation, and empowering education, Vella Bioscience is helping to close the pleasure gap and build resilient wellness infrastructure for women at every stage of life.Thank you for listening!If this episode inspired you, please screenshot and share it on social media—be sure to tag @meganswanwellness so we can cheer you on. Your support means the world!Connect with Megan SwanInstagram: http://www.instagram.com/meganswanwellnessLinkedIn: http://www.linkedin.com/in/megan-swan-wellnessWebsites: www.meganswanwellness.com + https://altavitahealth.ca/Subscribe to my Substack: ⁠⁠https://meganswan.substack.com/⁠⁠Buy the serum: https://vellabio.com/Keywordswomen's sexual wellness, femtech innovation, female arousal products, sexual wellness biotech, female pleasure serum, women's libido booster, female sexual dysfunction treatment, vagina moisturizer, CBD for women's health, clitoral arousal cream, female orgasm enhancement, sexual health education, science-backed pleasure product, hormonal imbalance solutions, menopause sexual health, antidepressant sexual side effects, arousal and lubrication, pleasure biohacking, holistic leadership for women, women's empowerment in wellness, women's health startups, sexual wellbeing for entrepreneurs, integrative sexual health, vaginal smooth muscle relaxation, topical sexual wellness products, retail sexual health expansion, women's health biohacking, clinically proven female pleasure, neurochemistry of orgasm, body literacy for women, sexual wellness retail trends

In this episode, Navneet sits down with Mads Lillelund, CEO of Qvin, the company behind the world's first FDA-cleared diagnostic menstrual pad. Qvin turns menstrual blood one of medicine's most discarded and dismissed biological samples  into clinical-grade diagnostic data. The pad currently detects biomarkers for diabetes (A1C), cervical cancer (HPV), endometriosis, STIs, ovarian cancer, and fertility, all non-invasively, all from a single use at home. In Stanford and Roche validation studies, Qvin detected 10% more HPV cases than the gold-standard pap smear. Mads brings over two decades of experience across enterprise tech, Fortune 500 companies, and high-growth startups into one of the most underfunded sectors in healthcare. His mission: to lead a Diagnostic Revolution by closing the gender data gap and making needle-free diagnostics accessible to the 1.8 billion people who menstruate worldwide including the 500 million experiencing period poverty.In this conversation, we go deep into:How Qvin is tackling some of the most overlooked and urgent challenges in women's healthWhat it really takes to navigate FDA clearance for a category-defining, first-of-its-kind productWhy the gender data gap remains one of the most dangerous blind spots in modern healthcareThe future of needle-free diagnostics and what it means for 1.8 billion women worldwideHow breakthrough innovation can scale across underserved and resource-constrained marketsWhat it means to lead as a male CEO in a space historically underfunded and overlookedThe complexity of building equitable pricing models in low-resource settingsThe realities of raising capital in FemTech and the systemic gender imbalance in venture fundingTune in to explore what happens if Qvin succeeds at scale a future where diagnostics are fundamentally redefined, where menstruation is no longer stigmatized but standardized in medicine, and where access to care is not determined by geography or income.This episode is brought to you in partnership with FemTech India a global women's health ecosystem building and scaling startups to close the gender gap in emerging markets like India.Disclaimer: The content shared in this episode is intended for general awareness and discussion purposes only. It should not be considered a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal health decisions. ©️TechThrive Ventures. All rights reserved.Newsletter - https://techthrivenewsletter.beehiiv.com/Qvin - https://qvin.com/Mads Lillelund - https://www.linkedin.com/in/mads-lillelund-9701278/Connect with us Instagram: ⁠⁠https://www.instagram.com/ctrl.alt.thrive.podcast/⁠⁠ Youtube :⁠⁠⁠ ⁠https://www.youtube.com/@Ctrlaltthrive/videosConnect with Navneet Linkedin : ⁠⁠https://www.linkedin.com/in/navneet-kaur-80109b227/⁠⁠Instagram : ⁠⁠https://www.instagram.com/nav_neeetkaur/⁠

In this episode, we dive deep into one of the most critical aspects of maternal health: hypertension and preeclampsia. Joining us is Fran Conti-Ramsden, an NHS Obstetrics and Gynaecology registrar and MRC-funded PhD fellow who is sitting at the fascinating intersection of clinical medicine and data science.Fran shares her expertise on why high blood pressure occurs during pregnancy, the "red flag" symptoms that often go unnoticed, and how she is using AI and real-world data to create a more equitable future for women's healthcare. Whether you are currently expecting, planning a family, or interested in how technology is transforming the NHS, this conversation provides essential medical insights and a look at the cutting edge of FemTech.What We Cover in This Episode:The Root Causes: Understanding the biological triggers of pregnancy-induced hypertension.Red Flags: The specific warning signs—beyond just a headache—that require immediate medical attention.The Impact on Mom and Baby: How high blood pressure affects fetal development and maternal recovery in the postpartum "fourth trimester."Risk Reduction: Practical steps involving nutrition, lifestyle, and medical interventions to manage your risk.The Long-Term Picture: Why a history of preeclampsia matters for your cardiovascular health years down the road.Innovation in Women's Health: How Fran is leveraging Natural Language Processing (NLP) and genomics to predict and improve pregnancy outcomes.Resources & Links:Download: Download the app here https://my.megi.ai/download/Support: Learn more about preeclampsia https://www.kcl.ac.uk/people/frances-conti-ramsdenpreeclampsia symptoms, high blood pressure in pregnancy, gestational hypertension, maternal health, FemTech innovation, Women's health AI, postpartum heart health, pregnancy complications, NHS clinical research, data science in healthcare, MRC clinical fellowship, personalized pregnancy care.www.NewMomTalk.comBuy Me A CoffeeIG: @NewMomTalk.PodcastYouTube: @NewMomTalkMariela@NewMomTalk.comInterested in being a guest? Shoot us an email!- best parenting podcast- best new mom podcast- best podcasts for new moms- best pregnancy podcast- best podcast for expecting moms- best podcast for moms- best podcast for postpartum- best prenatal podcast- best postnatal podcast- best podcast for postnatal moms- best podcast for pregnancy moms- new mom - expecting mom- first time mom

Follow Me Social Media:-Facebook: https://www.facebook.com/vivalavulvalaInstagram: https://www.instagram.com/vivalavulvalaWebsite: https://www.vivalavulvala.org/In this thought-provoking segment of the Viva La Vulva Podcast, Dr. Cara Quant and Lily Wang tackle the question: Is self-diagnosis the future of women's health? They explore how the advancements in FemTech are paving the way for women to take charge of their health through self-assessment tools and digital resources. Listeners will gain insights into the potential benefits and challenges of self-diagnosis, as well as how technology is empowering women to make informed health decisions. Join them for an eye-opening discussion on the evolving landscape of healthcare!

Follow Me Social Media:-Facebook: https://www.facebook.com/vivalavulvalaInstagram: https://www.instagram.com/vivalavulvalaWebsite: https://www.vivalavulvala.org/In this insightful segment of the Viva La Vulva Podcast, Dr. Cara Quant welcomes Lily Wang, CEOwner of MedAmour, to discuss the FemTech Revolution. They explore the implications of FemTech on women's health, including pressing concerns like privacy and inclusivity. With projections suggesting a market value of up to $1 trillion by 2030, the conversation examines the innovations driving this growth and whether they address the diverse needs of all women. Listeners will gain valuable insights into how FemTech is reshaping wellness while challenging societal norms around intimacy. Tune in for a thought-provoking dialogue on the future of women's health!

Follow Me Social Media:-Facebook: https://www.facebook.com/vivalavulvalaInstagram: https://www.instagram.com/vivalavulvalaWebsite: https://www.vivalavulvala.org/Join Dr. Cara Quant in this dynamic episode of the Viva La Vulva Podcast as she welcomes Lily Wang, the CEOwner of MedAmour. Together, they delve into the burgeoning world of FemTech, exploring its profound impact on women's health and wellness. From its definition as technology designed for female health to examining the significant issues of the gender health gap, this episode highlights how FemTech is reshaping our understanding of women's health. With a projected market value soaring between $60 billion and $1 trillion by 2030, Dr. Cara and Lily will sift through the innovations that are breaking taboos and empowering women with tools for better health management.In the second half of the episode, Lily shares her insights on MedAmour's approach to curating intimate wellness products that cater to diverse needs. Listeners will discover how products like the We-Vibe Jive 2 and We-Vibe Bloom are at the forefront of enhancing sexual wellness, providing users with innovative options for pleasure and health. This conversation not only celebrates the journey of FemTech but also SexTech and offers practical insights into the future of women's wellness that challenge societal norms and promote a healthier dialogue around intimacy. Tune in to explore how these advancements are revolutionizing the landscape for women everywhere!

In this episode of Disruption/Interruption, KJ sits down with Tracy MacNeal, CEO of Maternal Medical, to discuss a long-overlooked crisis in women's health: birth injuries. Tracy reveals how 10-15% of women who deliver vaginally experience severe pelvic floor trauma—injuries that often go undiagnosed and untreated for years. She shares how her company is developing groundbreaking technology to prevent these injuries during childbirth and why this space has been so dramatically underinvested. This conversation exposes the silence around maternal health and the urgent need for innovation in the delivery room. Four Key Takeaways: [11:28] The Hidden Epidemic of Birth Injuries - 10-15% of women who deliver vaginally suffer pelvic floor muscles torn off the bone—an injury only visible through ultrasound or MRI. This leads to pelvic organ prolapse, incontinence, and chronic pain, yet most women leave the hospital without knowing they've been injured. [5:22] Innovation Has Been Stalled for 80 Years - The epidural, introduced in the 1940s, was the last major innovation in labor and delivery. Unlike other medical fields that see constant advancement, maternal health has been dramatically underinvested, creating an anemic ecosystem for research and development. [20:12] Smart Technology That Listens to the Body - Maternal Medical's device gently pre-stretches the birth canal by listening to the mother's tissue and only expanding one millimeter at a time when the body relaxes. In clinical trials of over 200 patients, the device group had zero injuries compared to 11% in the control group. [30:58] The Power of Speaking Up - Women's silence about their symptoms has perpetuated the problem. When women speak up about birth injuries, it signals to investors that patients care and pushes physicians to prioritize these issues. Advocacy drives innovation and funding in healthcare. Quote of the Show (28:27):"Unless she's a fighter pilot, having a baby is the most dangerous thing most women will ever do."- Tracy MacNeal Join our Anti-PR newsletter where we’re keeping a watchful and clever eye on PR trends, PR fails, and interesting news in tech so you don't have to. You're welcome. Want PR that actually matters? Get 30 minutes of expert advice in a fast-paced, zero-nonsense session from Karla Jo Helms, a veteran Crisis PR and Anti-PR Strategist who knows how to tell your story in the best possible light and get the exposure you need to disrupt your industry. Click here to book your call: https://info.jotopr.com/free-anti-pr-eval Ways to connect with Tracy MacNeal: LinkedIn: https://www.linkedin.com/in/tracymacneal/Company Website: https://maternamed.com How to get more Disruption/Interruption: Amazon Music - https://music.amazon.com/podcasts/eccda84d-4d5b-4c52-ba54-7fd8af3cbe87/disruption-interruption Apple Podcast - https://podcasts.apple.com/us/podcast/disruption-interruption/id1581985755 Spotify - https://open.spotify.com/show/6yGSwcSp8J354awJkCmJlDSee omnystudio.com/listener for privacy information.

Março é o mês em que as discussões sobre mulheres ganham mais visibilidade — falamos sobre desigualdade salarial, representatividade e os desafios que ainda existem no mercado de trabalho. Mas, neste episódio, queremos provocar uma nova reflexão:Se metade da população é mulher… por que tantos produtos ainda não são pensados por e para mulheres?Neste episódio do Podcast Mulheres de Produto, Suelen Ramos e Rúbia discutem como o mito do “usuário neutro” influenciou a criação de produtos digitais ao longo da história e quais são os impactos reais quando a experiência feminina não é considerada no desenvolvimento de tecnologia.Ao longo da conversa, exploramos o crescimento de mercados como Femtech, soluções de autonomia financeira, apps de segurança e comunidades digitais — e também questionamos: estamos criando soluções reais ou apenas versões “cor-de-rosa” do que já existe?Mais do que falar sobre produtos para mulheres, este episódio levanta um ponto central: quem está criando esses produtos?Neste episódio você vai ouvir sobre:• O mito do “usuário padrão” e como ele impacta produtos digitais• O que realmente significa criar tecnologia para mulheres• O crescimento do mercado de Femtech e oportunidades pouco exploradas• O papel da diversidade nos times de produto• A importância de considerar recortes como raça, classe e maternidade• Tendências e o futuro da tecnologia voltada para mulheresTecnologia não é neutra.Design não é neutro.Dados não são neutros.E produtos também podem ser ferramentas de transformação.Queremos ouvir você:Se você fosse criar um produto para mulheres hoje, qual problema resolveria? Nos diga aqui no link⁠⁠⁠.- Compartilhe este episódio com uma mulher de produto- Marque a gente e conte qual produto você gostaria que existisseE siga o podcast para não perder os próximos episódios

AxisBIC, which drives innovation and supports start-ups in the Mid-West and South West, has seen an increase in the number of female entrepreneurs raising investment to grow their business. Figures for 2025 show that 35% of High Potential Start-Up (HPSU) approvals in the region were companies founded or co-founded by women, while 57% of Pre-Seed Start Fund (PSSF) approvals were female-led companies. AxisBIC, which works with businesses in Clare, Cork, Kerry and Limerick, revealed the figures ahead of International Women's Day as it encourages more women to take the leap into setting up their own company. Over the past five years at AxisBIC's flagship event, the Entrepreneur Experience, more than 50% of the participating businesses were founded or co-founded by women, far outstripping the national average of 25% to 30%. Figures show that these female-led businesses raised a total investment of €42 million. As well as the Entrepreneur Experience, AxisBIC organises a mini-accelerator and pitching event annually – the AxisBIC Venture Academy. Last year, Valentia Island Vermouth was named Most Investible Company and has subsequently been approved for PSSF funding and secured HPSU investment. Speaking about the win, founders Anna and Orla Snook O'Carroll said: "AxisBIC has been an exceptional support to us as founders, helping Valentia Island Vermouth strengthen our business strategy and prepare for long-term growth. Their guidance around planning, investor readiness and pitching was invaluable, particularly as 2025 became such a major milestone year for the company. We're proud to have secured PSSF funding, followed by HPSU investment, and AxisBIC's support was a key part of that journey. Being named Most Investible Company at the AxisBIC 2025 Venture Academy was also a brilliant endorsement of the progress we've made." The team at AxisBIC works closely with each entrepreneur to develop a well-tested business plan, raise investment, manage business propositions, and arrange agreements with shareholders and investors. The organisation has an extensive network of partners, including local authorities, universities, investors, business bodies and seasoned entrepreneurs across Ireland and internationally. CEO of AxisBIC, Larry O'Donoghue, said: "At AxisBIC, our commitment of supporting and advancing female-led startups is underpinned by a strong 'Give to Gain' ethos. The organisation draws on an extensive network of experienced entrepreneurs, investors and partners who mentor, coach and advise emerging founders. In addition, AxisBIC, together with the four Irish Business Innovation Centres (Irish BICs), has recently organised and supported Enterprise Ireland's newly established accelerator programme, NextWave. NextWave is the new National Women's founder Accelerator designed to empower women founders to validate, build and scale with confidence." Among the female start-ups supported by AxisBIC are Rosanne Longmore, of FemTech company Coroflo; Peigín Crowley, of health and wellness brand Ground Wellbeing; and Rena Maycock of Chirp, which is rewriting the script on mobile phone child protection. To mark International Women's Day, AxisBIC is co-hosting a webinar, 'Forging Collaboration and Sharing Entrepreneurial Success Stories to Balance the Scales', along with partner incubators in the EU and the Caribbean. The transatlantic conversation on Tuesday, March 10th, will feature female entrepreneurs from Jamaica, Barbados, Trinidad and Tobago, Ireland and Slovenia. Participating in the discussion will be Alice Carroll from Foxes Bow Irish Whiskey. Speaking ahead of the event, she said: "I have been driven by a mission to democratise whiskey. Building Foxes Bow Irish Whiskey has always been about challenging expectations and creating a more inclusive future for the category. AxisBIC has provided invaluable support through strategic business planning and a strong commitment to female entrepreneurs. I'm delighted to take part in the upcomin...

In this episode of Disruption/Interruption, KJ sits down with Oleg Kovalev, Chief Marketing Officer at Aspect Health, revealing how his company became the #1 women's hormonal health startup in the USA by disrupting traditional PCOS treatment. Discover how continuous glucose monitoring and lifestyle coaching are helping one in five women manage a condition that doctors have been treating wrong for decades—and how this medical innovation is driving explosive business growth. Four Key Takeaways: [4:21] PCOS affects 20% of women and is the #1 cause of infertility - Traditional medicine has underdiagnosed and undertreated PCOS for decades, leaving millions of women without proper answers or solutions beyond pills that mask symptoms. [8:33] Managing glucose levels can dramatically reduce PCOS symptoms - Simple lifestyle changes combined with continuous glucose monitoring help women see real-time correlations between their food choices and symptom improvement, leading to exceptional product retention. [17:24] Data-driven positioning beats gut feeling every time - Aspect Health grew 12x in nine months by systematically testing positioning through paid ads and user behavior metrics rather than relying on intuition or assumptions. [24:11] Ask what you should NOT be doing - Focus and intentionality come from eliminating tasks rather than adding them—the critical question every founder and marketer must answer to achieve breakthrough success. Quote of the Show (8:00):"When women go to doctor and they ask questions about PCOS, in most cases they don't get answers to their questions. Often they are given some standard protocol of taking some kind of pills." - Oleg Kovalev Join our Anti-PR newsletter where we’re keeping a watchful and clever eye on PR trends, PR fails, and interesting news in tech so you don't have to. You're welcome. Want PR that actually matters? Get 30 minutes of expert advice in a fast-paced, zero-nonsense session from Karla Jo Helms, a veteran Crisis PR and Anti-PR Strategist who knows how to tell your story in the best possible light and get the exposure you need to disrupt your industry. Click here to book your call: https://info.jotopr.com/free-anti-pr-eval Ways to connect with Oleg Kovalev LinkedIn: https://www.linkedin.com/in/alecko/Company Website: www.aspect-health.com How to get more Disruption/Interruption: Amazon Music - https://music.amazon.com/podcasts/eccda84d-4d5b-4c52-ba54-7fd8af3cbe87/disruption-interruption Apple Podcast - https://podcasts.apple.com/us/podcast/disruption-interruption/id1581985755 Spotify - https://open.spotify.com/show/6yGSwcSp8J354awJkCmJlDSee omnystudio.com/listener for privacy information.

In this episode of LERMA/'s Loud and Clear podcast, host Francisco “Pancho” Cardenas speaks with Lindsay Davis, founder and CEO of One Bee Consulting and founder and CEO of FemTech Association Asia. Lindsay shares her path from multicultural advertising in Dallas to luxury and international leadership in London, then relocating to Singapore in early 2020, where she discovered FemTech while moderating panels and reading Invisible Women. She describes FemTech as “female technology”—apps, SaaS, medical devices, wearables, and services spanning women's health across life stages, and emphasizes Asia as a large but still untapped market.The conversation outlines major barriers holding women's health back: it has been under-researched, underserved, and underfunded; stigma remains high (including a cited figure that 52% of women in Southeast Asia are uncomfortable discussing health needs openly due to fear of judgment or shame); awareness is low (42% don't use FemTech due to lack of awareness and understanding); and funding gaps persist (2.3% of total VC funding goes to women-founded companies, and only about 24% of VC decision makers in Southeast Asia are women). Lindsay also raises systemic content censorship, where women's health content is treated as risky or sexual—leading to downranking, shadowbans, and rejected ads—sharing examples like a breastfeeding support app removed for “nudity” and restrictions on terms such as “vaginal cancer,” with 95% of founders reporting content suppression.A central theme is how marketing and advertising can play a stronger role in education and normalization. Lindsay urges agencies and brands to start in-house by improving benefits, ERGs, and workplace support (including maternity return), and by offering inclusive health education programs. She argues advertising shapes culture and can drive health literacy through advocacy, PR, and more inclusive briefs that reduce gender bias. She suggests large agencies press major healthcare and pharma clients on their women's health strategies, while smaller agencies can support FemTech startups through affordable, fractional or retained marketing models aligned to early-stage budgets. Lindsay notes that in Asia many startups scale via corporate partnerships, and her association has grown into a cross-country network spanning 10 Asian markets, funded through corporate engagements and programming aimed at building awareness, trust, and access in women's health.Useful Links:Linkedin. Instagram.Web FemTech Linkedin Femtech Instagram Femtech UN report. Guest: ⁠⁠⁠⁠Lindsay Davis, Award-Winning Founder-FemTech Association Asia I Strategic Partnerships I Community Building I Customer Experience I Milken Institute I UN ESCAP I UNFPA I Tatler Front & Female Award I Board Advisor I Moderator/SpeakerProducers:⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠Victor Cornejo Tell Me More Studios⁠⁠⁠⁠⁠⁠ & ⁠⁠⁠⁠⁠Pranav Kumar at LERMA/⁠⁠⁠⁠⁠Host: ⁠⁠⁠⁠⁠⁠Francisco Cardenas, Executive Director, Brand Integration at LERMA/⁠⁠⁠⁠

Love the episode? Send us a text!When Breast Cancer Changes Everything — What Do You Build Next?What happens when a breast cancer diagnosis strips away your identity — and forces you to rebuild from the inside out?In this deeply personal and powerful episode of Breast Cancer Conversations, Laura Carfang sits down with Christine Handy and Christine Anastos — two breast cancer survivors who turned trauma into transformation.Christine Handy, former international model and author of Walk Beside Me, opens up about:Undergoing multiple mastectomy surgeriesBreast implant illnessReturning to the runway as a “breastless model”Turning her book into the award-winning film Hello BeautifulReclaiming worth beyond appearanceChristine Anastos (christine@connect-and-thrive.com), environmental engineer and founder of Connect & Thrive (CAT)  shares:Being diagnosed with DCIS while caregiving for her motherCancer's financial toxicity and hidden barriersWhy 90% of breast cancer cases may be environmentally influencedLaunching a public benefit corporation to bridge gaps in survivorship careTogether, these women explore:Identity after a cancer diagnosisFaith and post-traumatic growthThe myth of “doing it alone”Why collaboration is more powerful than competitionWhat it really means to be a “cancer disruptor”Welcome to the conversation. Support the showLatest News: Become a Breast Cancer Conversations+ Member! Sign Up Now. Join our Mailing List - New content drops every Monday! Discover FREE programs, support groups, and resources! Enjoying our content? Please consider supporting our work.

In this episode of The Wisdom Of ... Show, host Simon Bowen speaks with Lindsay Davis, Founder & CEO of FemTech Association Asia, the region's first and largest femtech network representing 80+ companies across 10 countries. From her global expansion leadership at Quintessentially to building an ecosystem that didn't exist, Lindsay shares profound insights on courage, ecosystem orchestration, and what it takes to drive systemic change in women's health across vastly different cultures and markets.Ready to systematically capture your leadership wisdom and turn it into scalable frameworks? Join Simon's exclusive Masterclass on The Models Method: https://thesimonbowen.com/masterclassEpisode Breakdown00:00 Introduction and the mission to advance women's health in Asia04:32 The career pivot from luxury brand expansion to femtech ecosystem building12:18 Why women's health receives only 4% of global R&D funding19:45 Building something that doesn't exist: October 2021 to 80+ companies across 10 countries28:36 The courage question - where resilience comes from35:52 Having a high threshold for shame and being happy failing42:28 The leadership lesson from someone who put aside their book49:15 Orchestrating founders, investors, corporates, governments around a single mission56:47 The UN ESCAP commission and defining transformational change01:03:22 FemTech Connect Asia: Creating the region's first femtech conference01:11:08 The suffragette movement insight and being part of the continuumAbout Lindsay DavisLindsay Davis started her career in multicultural advertising in the USA, then was recruited by the world's leading luxury lifestyle management brand, Quintessentially in the UK, to lead global expansion into 25 countries and oversee 60 offices worldwide, with secondments in NYC, China and Qatar. Davis was honoured on the Luxury Daily list of “Luxury Women in Watch” because of her global impact in the luxury sector. As the Founder & CEO of Singapore-based One Bee Consulting, Davis works with brands to develop and elevate loyalty solutions, customer experience and brand affinity through product development, content and programming, PR, community engagement and strategic partnerships.With a vision of available, accessible and affordable healthcare for all women in Asia, Davis founded FemTech Association Asia in October 2021 as the region's first and largest industry network for founders, professionals, and investors with the core focus on improving women's health through technology solutions. The organisation represents 80+ companies across 10 countries in Asia. FemTech Asia was a Finalist in the GIOF – 2022 Business Inclusivity Awards and is a member of the UNFPA Equity 2030 Alliance and a Founding Member of the Milken Institute Women's Health Network.In 2023-24, Davis was commissioned by the United Nations Economic and Social Commission for Asia and the Pacific (UN ESCAP) as a thought leader and researcher to define what is required to drive transformational and catalytic change in femtech in Southeast Asia. Davis is a contributor for the Milken Institute and sits on the Advisory Board for Women in Global Health – Singapore and Ovy Health in Indonesia.Connect with Lindsay DavisLinkedIn: https://www.linkedin.com/in/lindsay-davis-2584812/Instagram: https://www.instagram.com/femtechasia/Website: www.femtechassociation.comAbout Simon...

What drives someone to make their very first investment in a company that becomes a unicorn, and how can others follow suit? In this episode, host Marcia Dawood sits down with Jaclyn Johnson—serial entrepreneur, angel investor, and founder of Cherub—to unpack her journey from building and selling companies to becoming a prolific dealmaker and innovator in the fundraising space.Jaclyn Johnson shares her candid story, beginning with her initial leap into angel investing and continuing through her experience with high-profile exits and the founding of Cherub. The conversation also explores the challenges founders face today in fundraising, why many potential angels remain on the sidelines, and how Cherub is transforming access and simplicity for both founders and investors.This episode is a must-listen if you want to learn how successful angels think, discover what's changing in startup investing, or get inspired to start your own journey as an investor or founder. It's packed with practical wisdom and fresh perspectives on how to build a more inclusive and impactful entrepreneurial ecosystem. To get the latest from Jaclyn Johnson, you can follow her below!Jaclyn's LinkedinInvest with CherubCreate and Cultivate Sign up for Marcia's newsletter to receive tips and the latest on Angel Investing!Website: www.marciadawood.comDo Good While Doing WellLearn more about the documentary Show Her the Money: www.showherthemoneymovie.comAnd don't forget to follow us wherever you are!Apple Podcasts: https://pod.link/1586445642.appleSpotify: https://pod.link/1586445642.spotifyLinkedIn: https://www.linkedin.com/company/angel-next-door-podcast/Instagram: https://www.instagram.com/theangelnextdoorpodcast/Pinterest: https://www.pinterest.com/theangelnextdoorpodcast/TikTok: https://www.tiktok.com/@marciadawood

Breast cancer screening fails most often where access is constrained: limited appointments, geographic gaps, dense breast tissue, and reliance on self-exams that depend entirely on human touch. Awareness alone doesn't close those gaps.In this episode, Dr. Karny Ilan, co-founder and CEO of Feminai, shares how physician-led product design, multidisciplinary collaboration, and rigorous clinical trials shaped a new model for breast screening access. The conversation explores a shift in how breast health is managed—from episodic screening to continuous, individualized monitoring. Rather than relying on infrequent appointments alone, it examines tools designed to track changes over time, at home, while remaining connected to clinical decision-making. Timestamps(00:11) Breast cancer risk shaped by genetics and lived exposure(08:37) Limits of traditional self-breast exams(09:09) Personal experience shaping breast health urgency(10:15) How at-home breast scanning detects change over time(12:42) Designing screening tools for dense breast tissue(17:03) Addressing breast size, shape, and post-surgical variation(18:31) Clinical trials revealing real-world usability gaps(20:13) Why ease of use affects screening reliability(29:29) Access gaps amplified by pandemic-era screening delays(38:09) Broad inclusion across age, risk, and body types Guest BioDr. Karny Ilan — Co-Founder and CEO, FeminaiDr. Karny Ilan is a general surgery resident at Sheba Medical Center and the co-founder and CEO of Feminai, a breast health company developing an AI-enabled disposable wearable patch and app for at-home breast exams. With a strong family history of breast cancer, she brings clinical experience and patient-centered design to building scalable screening tools that expand access and personalization.LinkedIn: https://www.linkedin.com/in/karny-ilan/Key PointsAccess constraints drive missed detection: Feminai targets screening gaps caused by geography, capacity, and avoidance.Physician-led design builds trust: Clinical credibility accelerated adoption with providers and investors.Dense breast tissue is a priority use case: The technology is designed to perform well where mammography often struggles.Personalized baselines change detection logic: Each scan is compared against the user's own prior data.Usability directly affects accuracy: Instructions, fit, and behavior shape downstream AI performance.Deep Dives1. At-home breast exams as infrastructureDesigned for frequent, low-friction useComplements rather than replaces imaging2. Patch and app workflowRisk stratification via medical questionnaireBluetooth-enabled scan uploads to secure cloudAI analysis with physician review3. Designing for every bodyStretch materials accommodate size variationDense tissue explicitly accounted forAdditional sizes planned as rollout expands4. Clinical trials beyond performance metricsUsability drove multiple design iterationsInstruction format affected adherenceShape changes required algorithm updates5. Personalized longitudinal trackingEach woman compared only to herselfChanges flagged based on deviation, not population averages6. Leadership and multidisciplinary teamsEngineers exposed to clinical sitesPatient stories shared to reinforce missionStability in leadership communication protected executionLinks & ReferencesBreast cancer screening beyond mammography (Mayo Clinic): https://www.mayoclinic.org/tests-procedures/mammogram/in-depth/breast-cancer/art-20047233Breast cancer screening recommendations (USPSTF): https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening

Midlife health decisions rarely fail because women “don't know what to do.” They fail because the stakes change overnight, the calendar stays overloaded, and the system you used to rely on stops working.This conversation sits at the intersection of two realities: breast cancer can show up even without family history, and the perimenopause to menopause transition forces a new level of precision around hormones, bone health, fatigue, and what you put on your skin.In this episode, Sally Mueller, co-founder of Womaness, speak candidly from lived experience—diagnosis timelines, treatment tradeoffs, dense breast screening gaps, and the unglamorous but decisive habits that actually keep women on track.Timestamps(03:16) Following instincts as an early prevention strategy (11:18) Clean, hormone-free formulations and long-term exposure risk (12:58) Hereditary versus environmental drivers of breast cancer (20:20) Dense breast tissue and proactive screening strategies (27:31) Vitamin D deficiency and systemic fatigue signals (28:49) Supplement consistency versus reactive use (32:32) Why steady supplementation outperforms short-term fixes (36:18) Bone health through impact, resistance, and movement variety (40:07) Exercise variation as a stimulus for bone remodeling (41:47) Treating exercise like a non-negotiable meeting Guest BioSally Mueller — Co-Founder and CEO, WomanessSally Mueller is the co-founder of Womaness, a women's wellness brand focused on perimenopause and menopause solutions across skin, body, supplements, and sexual wellness.LinkedIn: https://www.linkedin.com/in/sally-mueller/Key PointsMidlife health breakdown is often a systems failure, not a motivation problem: Delayed screenings, inconsistent supplements, and deprioritized movement compound risk over time.Early detection depends on follow-through, not awareness: Dense breast tissue, hormone shifts, and missed baselines create blind spots when care is delayed.Consistency beats intensity in supplements and exercise: Vitamin D, bone-loading movement, and simple routines outperform sporadic “health resets.”Clean inputs matter more after cancer, but should start earlier: What women put on and in their bodies becomes more consequential during hormonal transition.Exercise functions as prevention infrastructure, not lifestyle garnish: Impact, resistance, and aerobic movement materially affect recurrence risk, bone density, and fatigue.Deep DivesDelayed care as a compounding risk factorMissed appointments increase exposure windowsDelays often happen during peak hormonal volatilityDense breast tissue and the screening gapMammograms alone can miss early signalsUltrasound and MRI baselines improve detectionVitamin D deficiency as a hidden performance drainFatigue and joint pain can signal depletionWinter and low sun accelerate declineSupplement discipline versus reactive useInconsistent intake reduces benefitFewer supplements taken regularly outperform complex stacksBone health beyond medicationImpact and resistance stimulate bone remodelingMovement variety matters more than volumeExercise as a protective interventionAerobic activity reduces systemic disease riskStrength work supports bone and joint resilienceClean formulations and cumulative exposureHormone-free products reduce added loadTransparency matters more during midlife transitionsWhy midlife routines collapse firstCaregiving, careers, and stress convergeHealth behaviors are usually the first to dropTreating exercise like a meetingScheduled movement increases adherenceNon-negotiable time blocks protect consistencyPrevention as an operating modelMidlife health requires durable systemsShort-term fixes fail under long timelinesLinks & ReferencesBreast cancer screening beyond mammography (Mayo Clinic): https://www.mayoclinic.org/tests-procedures/mammogram/in-depth/breast-cancer/art-20047233Vitamin D deficiency, symptoms, and testing (National Institutes of Health): https://ods.od.nih.gov/factsheets/VitaminD-Consumer/Exercise and bone health in midlife and beyond (International Osteoporosis Foundation): https://www.osteoporosis.foundation/health-professionals/prevention/exercise

For a number of years now, the innovative field of femtech has been revolutionising how we approach healthcare for women. Technology already touches just about every aspect of our lives, and healthcare is no exception. Now femtech focuses specifically on addressing various aspects of women's health, from contraception to diseases that predominantly affect women. It may have Initially been overlooked, but femtech has now emerged as a significant market in its own right.  When did the term first appear? Would you say that femtech is a booming sector? In under 3 minutes, we answer your questions! To listen to the last episodes, you can click here: ⁠Why is sugar bad for our memory?⁠ ⁠Does the law of attraction really work?⁠ ⁠How can I stay trendy buying only second hand clothes?⁠ A podcast written and realised by Joseph Chance. First Broadcast: 6/3/2024 Learn more about your ad choices. Visit megaphone.fm/adchoices

新年快乐！���Bessie 与品牌专家李倩共同开启全新系列「她们的底线 倩与倩」。这是一档从女性经验出发，审视商业与产品的女性视角对谈节目。我们跳出固有框架，聚焦那些被默认 “理所当然” 的需求，通过探讨具体产品与产业的发展脉络，挖掘背后隐藏的商业逻辑、投资判断与社会心理。在一次次谈论中，重新锚定女性在商业世界里的真实位置，让被忽视的需求被看见、被重视。欢迎收听！本期做为系列开篇，我们选取了两个几乎陪伴大半人生、使用年限相当的性别产品谈起—女性的卫生巾，与男性的剃须刀。二者同样高频、同样不可或缺，却走上了截然不同的商业路径：剃须刀从安全刀片迭代至智能设备，衍生出订阅制商业模式，甚至成为身份体面的象征，获得资本持续青睐；而卫生巾自诞生起便笼罩在 “羞耻感” 之下，从战场止血材料转为 “不能明说” 的商品，百年进化仅停留在 “更薄、更干、更隐形” 的功能优化，连最基本的安全与质量都只是在舆情争议中才进入讨论。本期内容我们不讨论性别公平，只是用这一相伴人生的产品做一个冷静的商业对照：当产品被定义为 “私人麻烦” 而非 “正当需求”，创新为何会陷入停滞？当女性自身都对需求隐忍克制，商业又如何主动回应？从研发团队的性别结构、资本的投资逻辑，到 “卫生巾羞耻” 带来的需求表达缺失，我们来认真探讨下卡住卫生巾进化的真正原因是什么，探索女性需求从 “被满足” 到 “被重视” 的商业可能。【本节目由Withinlink碚曦投资协作体出品】【主持】李倩玲 Bessie Lee广告营销行业资深从业者，商业观察者李倩品牌专家，“李倩说品牌”公众号作者，添梯品牌咨询创始人小红书：李倩说品牌【本期内容提要】[00:12]新系列「她们的底线 倩与倩」的缘起，我们为什么要用女性视角看商业？[04:27]为什么选择卫生巾 vs 剃须刀这两个使用年限几乎贯穿一生却命运不同的产品作为第一期的内容？[05:31]同款刚需产品，为何走向了完全不同的迭代路径[09:35]从战场上的止血材料到“不能被提及的商品”的女性用品[12:55]“更薄、更无感”的进化逻辑，究竟在解决谁的问题[16:44]卫生巾创新不足是技术问题还是需求长期模糊？[21:15]为什么剃须刀被视为值得升级的产品[21:41]剃须刀的商业路径：从工具属性到商业模式更新，再到身份符号[31:01]“麻烦型” 需求为何难逃低价与低创新宿命？[36:31]耗材和工具在投资和研发逻辑上具有根本差异[41:49]研发、投资与性别结构占比会影响产品创新[44:14]女性需要主动为自身需求提要求[52:10]FemTech女性健康科技、女性创始人带来的新的行业想象[53:55]定位、技术与资本相互协同作用塑造了两条截然不同的百年路径[01:01:50]女性是否愿意、是否能够为真实需求支付溢价，设定新的标准？[01:03:00]需求与商业创新的四个思考维度[01:08:40]本系列节目将继续从具体产品出发，一起和大家讨论被忽视的需求【后期制作】Jean【收听方式】推荐您使用Apple Podcast、小宇宙APP、喜马拉雅、荔枝播客、网易云音乐、QQ音乐、Spotify或任意泛用型播客客户端订阅收听《贝望录》。【互动方式】微博：@贝望录微信公众号：贝望录+商务合作：beiwanglu@withinlink.com

Welcome to Perimenopause WTF!, brought to you by ⁠Perry⁠—the #1 perimenopause app and safe space for connection, support, and new friendships during the menopause transition. You're not crazy, and you're not alone!  Download the free Perry App on ⁠Apple⁠ or ⁠Android⁠ and join our live expert talks, receive evidence-based education, connect with other women, and simplify your perimenopause journey.Today's episode is titled “From Surviving to Thriving: Navigating Perimenopause in the Workplace” with Dr. Mache Seibel & Dr. LaReesa Ferdinand. Perimenopause shouldn't be the end of a woman's career peak, yet the combined weight of workplace stigma and rising anxiety often leaves women feeling forced out of the workforce. Dr. Mache Seibel and Dr. LaReesa Ferdinand reveal the staggering financial loss companies face when they lose seasoned female talent and provide a vital roadmap for securing the accommodations needed to protect both a woman's career and mental health.

Why We Still Can't Say ‘Vagina' at Work, and What It's Costing Women in Leadership. Ugh. I know. But there's hope:What if the biggest barrier to women's leadership isn't a lack of confidence, but the shame we're taught to carry about our own bodies?In this episode, Helena sits down with Kamola Mir, CEO and founder of Lidovex, a health-tech company building the world's first cervical (data) ecosystem. What begins as a conversation about fem-tech quickly expands into a deeper truth:You cannot build a world that values women if you still devalue the female body.From being laughed at on stage for saying the word “vagina,” to navigating investor meetings where a woman's worth is often assessed before her work isKamola breaks down the emotional, biological, and cultural realities women face when they lead inside male-designed systems.Together, we explore:Why de-stigmatizing women's bodies is a leadership issue, not a “women's topic”How shame shapes everything from our ambition to our burnout cyclesWhy female biology is not a weakness, but a strategic advantageThe hidden mental load female founders carry in every roomHow to stay authentic when the world rewards you for fitting inHow to build inner power even when the system feels riggedThis is an episode for every woman who has ever hustled through pain, silenced her intuition to appear “professional,” or tried to win inside a structure that was never built for her.If you're ready to unlearn the shame, reclaim your biology, and lead from a place of grounded power, this one is for you.Chapters:00:55 Intro: Why femtech isn't niche but a cultural revolution01:20 Moving past generations of research centered on white men02:16 The rise of women leading taboo-breaking innovation02:49 How women are finally steering investment and change03:37 Celebrating Kamola Mir, Founder/ CEO reshaping women's health with Lidavex: Building an ecosystem that returns ownership to women's bodies04:16 Kamola's Trauma: childbirth care built without women in mind06:00 Leaving patriarchal workplaces, listening to our inner voice and create the change we need in the world07:30 Women must fight for their bodies09:07 The moment intuition becomes survival in labor10:41 Why women need both intuition and data to lead well12:06 How shame still silences women's conversations about our bodies13:03 Reclaiming our anatomy and naming our truths without fear15:01 When saying “vagina” triggers giggles and how to speak up17:09 Patriarchy at work and why women don't fit the 9–5 mold19:37 Redefining productivity through the wisdom of female cycles21:08 Navigating sexualization while trying to lead authentically24:26 Three ways women can release shame and rise into leadership29:43 Building an immune system for disagreement and staying grounded under pressure31:53 The emotional cost of being ‘fuckable' in male-dominated spaces & how to deal with it33:07 Showing up empowered while navigating safety, power, and perception37:53 Knowing when to adapt, when to walk away, and when to stand your ground43:01 Why patriarchal hustle culture breaks women's bodies and how to reclaim balance Connect with Kamola on LinkedInDiscover, stay up to date, fund and support Lidovix' journey: Website and LinkedInUntil next time!! xx Connect with me:IG: https://www.instagram.com/whereboundariesdissolvepodcast?igsh=OGQ5ZDc2ODk2ZA%3D%3D&utm_source=qrTikTok: https://www.tiktok.com/@helena.arjuna?_t=8oSbtTilPSQ&_r=1LinkedIn: https://www.linkedin.com/in/helenasuter/ Youtube: https://youtube.com/@whereboundariesdissolvepodcast?si=g63NToOK45W1CiBI Support the show

So many unmet needs - so many opportunities for meaningful solutions. Given the number of potentially game-changing start-ups in the FemTech & Women's Health spaces, we need to support these startups the best we can. That's exactly what this week's guest, Theresa Neil, does as Founder & CEO of Femovate - the largest global design program for early-stage FemTech startups. Hear why FemTech startups can benefit from design & research support and how we can meet women's health needs today. Learn how Femovate selects the startups it partners with, the insights Theresa is gleaning working across sectors, and some of the most exciting innovations in the women's healthcare space today. Tune in to this episode to support the next great women's health innovations.   Learn more: Femovate Femovate LinkedIn Theresa Neil   Today's Hot Flash and other stats from: National Institutes of Health (NIH)

Ihren Laptop klappt sie um 16 Uhr zu, dann sind zu 100% ihre Kinder dran. Davor aber geht es bei Anna- Lena Hudalla rund: KI, Frauen, Gesundheit. Das sind die Themen der leidenschaftlichen Unternehmensgründerin.

Technology to improve rowing athletes' performances, zero-waste clothing design, and a safer and more comfortable Intrauterine Device (IUD) were among the start-ups highlighted at this year's University College Cork's IGNITE Autumn Showcase. The third-level graduates supported by the university's flagship incubation programme began working on their ideas this year and are hoping to develop them into a company with the assistance of IGNITE. The 2025 Autumn Showcase follows IGNITE's recent success in securing a €1 million Higher Education Authority (HEA) Award for exemplary performance and impact. The HEA evaluated Impact Assessment Case Studies, which were submitted by higher education institutions earlier this year. IGNITE emerged as one of five winning submissions. IGNITE is based at UCC and is open to anyone who has graduated from a third-level institution in recent years and has the passion and ambition to work on an idea that has the potential for economic, environmental or social impact. The annual showcase gives the IGNITE participants an opportunity to network with other entrepreneurs and potential investors. IGNITE has supported nearly 250 founders since it was established in 2011. The programme is a joint initiative by Cork City Council, Cork County Council, the Local Enterprise Offices of Cork City, South Cork and North and West Cork and University College Cork. Eamon Curtin, Director of IGNITE, said: "We are proud at IGNITE to support talented founders in developing their innovative business ideas into scalable and sustainable start-ups that deliver real social and economic value. The HEA Award is a testament to not only the great work carried out by our community of entrepreneurs, but also to the support provided to us by the Local Enterprise Offices, Cork County Council, Cork City Council and Bank of Ireland, without whom the programme would not be possible." Among the 14 start-ups currently supported by University College Cork's IGNITE Start-Up Incubation Programme are: Roteq - founded by Will Gunnarson and Sam O'Neill. Roteq empowers rowing athletes to reach their full potential by providing actionable insights into their performance. By processing data from a phone's built-in sensors, the programme delivers real-time performance metrics. These quantifiable metrics allow instant feedback and tracking of an athlete's technical and physiological progress on the water, making it easier than ever to achieve their goals. The Zero Waster - founded by Sarah O'Neill. Sarah is a designer whose work is grounded in the principles of regenerative design. With a deep-rooted respect for natural materials, traditional craftsmanship, and environmental responsibility, Sarah challenges the norms of the fashion industry through innovative reuse and transparency. Creating unique, wearable pieces from reclaimed and natural materials, showing that waste can be reimagined without compromising creativity or quality. Elithiya - founded by Isabelle Curran. Isabelle is a Product Design & Technology graduate from the University of Limerick and the founder of Elithiya, a women's health innovation focused on redesigning the intrauterine device (IUD) experience. Over the past year, she has collaborated with clinicians, FemTech founders, and patients worldwide to identify gaps in reproductive healthcare and develop a softer, more informed IUD insertion experience through redesigned tools and supportive digital technology. More about Irish Tech News Irish Tech News are Ireland's No. 1 Online Tech Publication and often Ireland's No.1 Tech Podcast too. You can find hundreds of fantastic previous episodes and subscribe using whatever platform you like via our Anchor.fm page here: https://anchor.fm/irish-tech-news If you'd like to be featured in an upcoming Podcast email us at Simon@IrishTechNews.ie now to discuss. Irish Tech News have a range of services available to help promote your business. Why not drop us a line at Info@IrishTechNews.ie no...

Send us a textWhat do you do when you realize you want to build a career in healthcare outside of the clinic?In this episode, we sit down with Kaylee Johnson, a former Career Clarity Program member and inspiring success story, who has built a fulfilling career spanning neuro-occupational therapy, program design, women's health entrepreneurship, AI-enabled HealthTech, and now FemTech operations.Kaylee shares:The full landscape of healthcare careers beyond doctors and nursesWhat sparked her shift from clinical work into strategy, sales, and operationsThe exact steps and tools she used to make the transition (including the Career Clarity Program)Her advice for anyone craving a more mission-driven second act in their careerIf you're dreaming of a meaningful career change, especially within healthcare or tech, this episode shows what's possible.Resources from Kaylee:LinkedInPodcastsWomen at WorkBeyond These Clinic WallsWhen Mommy Grows UpBooks Susy Welch - Becoming You ----------------------------- You are one click away from boosting your career clarity and confidence!Head over to whenmommygrowsup.com where you'll find the free Career Clarity Kickstart. With this free on-the-go guide, we'll walk you through 5 clear action steps you can take to go from confused about next steps to confident about what you want and need from your career. Get started today!

In this Mission Matters episode, ⁠Adam Torres⁠ interviews ⁠Lindsay Davis⁠, Founder of FemTech Association Asia, about leading Asia's growing femtech ecosystem. Davis shares how the association connects 80+ startups across 10 countries, fostering innovation and collaboration in women's health, advocacy, and technology. Follow Adam on Instagram at ⁠https://www.instagram.com/askadamtorres/⁠ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: ⁠https://missionmatters.lpages.co/podcastguest/⁠ Visit our website: ⁠https://missionmatters.com/⁠ More FREE content from Mission Matters here: ⁠https://linktr.ee/missionmattersmedia⁠ Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this Mission Matters episode, Adam Torres interviews Lindsay Davis, Founder of FemTech Association Asia, about leading Asia's growing femtech ecosystem. Davis shares how the association connects 80+ startups across 10 countries, fostering innovation and collaboration in women's health, advocacy, and technology. Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: https://missionmatters.lpages.co/podcastguest/ Visit our website: https://missionmatters.com/ More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices

Dr. Elina Berglund, particle physicist turned femtech pioneer, unpacks how Natural Cycles (code: BIOHACKING) is transforming women's health through data, wearables, and AI. Dr. Elina shares how her search for a hormone-free birth control method led to creating the world's first FDA-cleared digital contraceptive. Today, Natural Cycles is expanding far beyond fertility — into perimenopause, menopause, and even male contraception research. If you're a modern, health-curious woman who wants to understand your hormones from your first period to menopause — through science you can actually trust — this episode is your roadmap. WE TALK ABOUT:  07:00 – Dr. Elina's journey from CERN physicist to femtech founder 11:30 – How Natural Cycles helps women avoid or plan pregnancy naturally 14:15 – The power and limits of wearables like Oura and the new Natural Cycles Band 24:05 – Postpartum tracking and why breastfeeding moms still need data 29:05 – The perimenopause feature and how temperature reveals hormonal shifts 37:15 – Data privacy, GDPR, and protecting sensitive health data 40:30 – AI innovations and future possibilities for male contraception 45:10 – The importance of fertility education for teens SPONSORS: CaloCurb (get 10% OFF) is my go-to, 100% plant-based alternative to Ozempic—helping you feel full sooner, snack less, and finally trust your body again without needles, drugs, or yo-yo diets. Join me in Costa Rica for Optimize Her, a 5-night luxury women's retreat in Costa Rica with yoga, healing rituals, and biohacking workshops—only 12 spots available. RESOURCES: Trying to conceive? Join my Baby Steps Course to optimize your fertility with biohacking. Free gift: Download my hormone-balancing, fertility-boosting chocolate recipe. Explore my luxury retreats and wellness events for women. Shop my faves: Check out my Amazon storefront for wellness essentials. Natural Cycles website (code: BIOHACKING) and Instagram LET'S CONNECT: Instagram, TikTok, Facebook Shop my favorite health products Listen on Spotify, Apple Podcasts, YouTube Music

In this interview, healthcare futurist Reenita Das, Partner at Frost&Sulivan, Healthcare Changemaker, voted top 100 women in Healthtech and Femtech, reflects on the balance between rapid digital health innovation and the human side of care. Speaking from WHX Tech in Dubai, she highlights why empathy, kindness, and caregiving remain essential despite the rise of AI. She also shares insights on the UAE healthcare system—its sophistication, inequities for migrant workers, and opportunities in mental health and digital innovation. Drawing from her experience in 10+ healthcare systems worldwide, Reenita compares global approaches and emphasizes food and lifestyle as drivers of health outcomes. 00:00 – Introduction and reflections on WHX Tech conference 01:00 – Why the human side of healthcare is more important than ever 02:30 – Risks of AI reducing clinician-patient time 03:30 – What AI can and cannot do in healthcare 05:00 – UAE healthcare system: sophistication and inequities 06:30 – Migrant workers and challenges of access to care 07:00 – Comparing healthcare systems across the US, Japan, and India 08:30 – Food and lifestyle as drivers of health outcomes 09:30 – Digital health opportunities in the UAE (mental health, diagnostics, aggregation) 10:30 – Misconceptions about women, culture, and technology in the UAE 11:30 – Advice for startups entering the region www.facesofdigitalhealth.com https://fodh.substack.com/

Kirsten Karchmer, founder of Conceivable, is one of North America's first reproductive acupuncturists. With a career spanning clinical practice, software development and AI integration, Kirsten brings a fresh, deeply personal perspective to the future of women's healthIn this episode, we explore the root causes of infertility and why simply timing intercourse isn't enough. Kirsten breaks down the concept of the “Conceivable Cycle,” how subclinical symptoms reveal deeper fertility issues, and why most women are misled by generic wellness advice. She also shares the story behind building an AI-powered virtual care platform, one designed not to replace doctors, but to give millions of women access to tools that previously cost tens of thousands in clinical care.We also talk about IVF, when it should be used, and how even women in their 40s can significantly boost fertility outcomes by improving internal health metrics. The conversation ends with Kirsten's advice to female founders, the role of automation and AI in running a business and how her unexpected obsession with houseplants helps restore balance in a founder's high-stress lifeTimestamps:[00:00:45] From MS Diagnosis to Reproductive Medicine[00:02:26] Why Fertility Monitors May Be Doing More Harm Than Good[00:04:22] How to Actually Know If You're Fertile[00:05:00] What the “Conceivable Score” Reveals[00:07:04] Building an AI OS for Women's Health[00:10:15] Signs of a Healthy vs. Unhealthy Menstrual Cycle[00:13:46] When IVF Makes Sense and When It Doesn't[00:16:03] Fertility After 35: Misconception or Reality?[00:18:00] The Resistance (and Reception) from Clinicians[00:21:02] Advice for Female Founders and Women in FemTechGet in touch with Kirsten - ⁠https://www.linkedin.com/in/kirsten-karchmer-0139808/ ⁠Learn more about Conceivable - ⁠https://conceivable.com/⁠Get in touch with Karandeep Badwal - ⁠https://www.linkedin.com/in/karandeepbadwal/ ⁠Follow Karandeep on YouTube - ⁠https://www.youtube.com/@KarandeepBadwal⁠Subscribe to the Podcast

Navigating menopause as a Latina woman often means facing it alone—without adequate information, representation, or community support. On this episode of Pleasure in the Pause, host Gabriela Espinosa sits down with Emmy-winning journalist and entrepreneur Gaby Natale to discuss how she's revolutionizing menopause education for Latinas through her groundbreaking bilingual platform, Menopausia.com.Whether you're struggling with medically-induced menopause after breast cancer treatment, searching for reliable information in Spanish, or simply tired of outdated depictions of midlife women, this conversation offers validation, solutions, and a roadmap for reclaiming your power during this transformative life stage. Gaby shares her journey from breast cancer survivor to menopause advocate, revealing why Latinas experience longer transitions and how breaking the silence can literally save lives.Are you ready to awaken your sensuality and feel more empowered in your body? Access the FREE Pleasure Upgrade Bundle at https://www.pleasureinthepause.com/gift.Gaby Natale is a three-time Daytime Emmy Award-winning journalist, bestselling author, entrepreneur, and leadership speaker. She made history as the first Latina to win three consecutive Daytime Emmys and the first Hispanic author published by HarperCollins Leadership. Recognized by People Magazine as one of the 25 Most Powerful Latinas and by Success Magazine as a Woman of Influence, Gaby is also a breast cancer survivor and official ambassador for Susan G. Komen.Most recently, she founded Menopausia.com, the first bilingual FemTech platform dedicated to Latinas navigating perimenopause and menopause. Her bestselling book, The Virtuous Circle, provides a framework for reinvention and breaking barriers. Connect with her on Instagram @gabynatale and explore Menopausia.com for comprehensive menopause resources in English and Spanish.Highlights from our discussion include:Stop waiting for permission or copying what others do. Real transformation happens when you trust your own vision before the world validates it.The menopause transition lasts approximately two years longer for Latina women, with the average age being 48 instead of 51. Women in the US typically see 4-5 different doctors before finding adequate menopause solutions.Gaby's "Virtuous Circle" model identifies seven archetypes that drive successful transformation.The depressing, outdated imagery typically used to portray menopausal women perpetuates shame and invisibility.Menopause doesn't have to be navigated in isolation or shame. By sharing our stories, breaking cultural silence, and accessing reliable bilingual resources, we can ensure the next generation of women enters this transition with knowledge, community, and confidence.Learn more about Menopausia.com here:https://menopausia.com/Instagram: https://www.instagram.com/menopausiacom/Connect with Gaby here: https://www.instagram.com/gabynatale/https://www.youtube.com/@GabyNataleOKBuy Gaby's book The Virtuous Circle here: https://a.co/d/1XFKKNFCONNECT WITH GABRIELLA ESPINOSA:InstagramLearn more about Menopausia.com here: https://menopausia.com/Full episodes on YouTube.

Stephanie Link, Chief Investment Strategist and Portfolio Manager at Hightower Advisors, unpacks investor sentiment, tech innovation, and demographic shifts, and what's next for Q4 and beyond.

(Airpods Recommended) In this episode, you'll learn how women's health is often dismissed, censored, and underfunded. Michele and Bethany discuss patient advocacy, informed consent, and navigating FemTech safely using the SAFE framework (Security, Accuracy, Foundation, Equity). Bethany shares her personal experiences that led her to this work. They also explore historical neglect, and highlight innovations and privacy challenges, all while giving a sneak peek of Bethany's upcoming book, The Femtech Revolution. Share this episode with every woman you know!   KEY TOPICS A New Chapter: Podcast Rebrand and Women's Health Dive (0:00) Personal Battles Fueling the Fight for Women's Health (3:13) Navigating Dismissal: How to Advocate for Your Health (9:19) Demanding Documentation: Understanding the Standard of Care (16:08) The Dark History of Gynecology: Dr. Sims' Experiments (19:45) Shocking Reality: Pelvic Exams Without Patient Consent (24:27) Dismissed Pain: Gender Bias in Medical Treatment (30:23) Dangerous Gaps: Neglect in Women's Drug Research (34:36) What is Femtech? Innovations for Women's Health (37:48) The Censorship Battle: Femtech Advertising Challenges (39:57) Protecting Your Health Data: The SAFE Framework Explained (44:21) Rise Up: Demand Better Women's Health and Innovation (55:00)   RESOURCES MENTIONED JOIN MICHELE'S NEWSLETTER FOLLOW on YOUTUBEMichele's Book: Design A Life You Love: A Woman's Guide to Living a Happier and More Fulfilled Life   GUEST INFORMATION Website: www.femtechlawyer.com Book: The Femtech Revolution: Harnessing Technology to Supercharge Women's HealthcareIG: @FemtechLawyer Articles Referenced: Elle article – https://www.elle.com/life-love/a28125604/nonconsensual-pelvic-exams-teaching-hospitals/?utm_source=chatgpt.com https://www.sciencenews.org/article/pelvic-exam-informed-consent-guidelines   If you enjoyed this interview, please take a moment to rate and review it on Apple Podcasts or your podcast player   Guest Bio: Bethany Corbin is an award-winning healthcare innovation attorney and femtech entrepreneur. She is the Founder and Managing Partner of Women's Health Innovation Consulting, the first law firm in the U.S. dedicated exclusively to serving women's health innovators. She is also the Co-Founder of the Women's Digital Health Network, and the Founder and CEO of FemInnovation. Both companies help disrupt “standard” care delivery for women's health.   *The Good Life with Michele Lamoureux podcast and content provided by Michele Lamoureux is for educational and entertainment purposes only. It does NOT constitute medical, mental health, professional, personal, or any kind of advice or serve as a substitute for such advice. The use of information on this podcast or materials linked from this podcast or website is at the user's own risk. Always consult a qualified healthcare or trusted provider for any decisions regarding your health and wellbeing.  

The Future of Femtech and Why Women's Health Matters to All.In this new episode of Narratives of Purpose's special series from the 2025 HIMSS European Health Conference, host Claire Murigande speaks with pioneering tech founder Ida Tin, the Co-founder of Clue and the Founder of Femtech Assembly think tank.Ida explores the evolution of the Femtech sector since she coined the term in 2016. She empahsizes the necessity for women's health to be acknowledged as a social imperative and to consider its implications for everyone. Ida advocates for framing women's health issues within the broader context of societal well-being.Ida also argues that fostering understanding and empathy among men regarding women's health experiences is essential for creating a more equitable society. True progress requires brave dialogue and shared experiences, with both genders actively participating in reshaping narratives around health.Be sure to visit our podcast website for the full episode transcript.LINKS:Connect with Ida Tin: LINKEDIN Read 'Femtech Assembly by Ida Tin' on SubstackLearn more about the Clue app at helloclue.comFind more information on Daye, the innovative period care and gynae health company, at yourdaye.comFollow our host Dr. Claire Murigande: WEBSITE | LINKEDINFollow us: LinkedIn | Instagram Connect with us: narrativespodcast@gmail.com | subscribe to our news Tell us what you think: write a review This interview was recorded by Megan McCrory from the SwissCast Podcast Network. This series was produced with the support of Shawn Smith at Dripping in Black.CHAPTERS:00:00 - The Importance of Women's Health in Society01:21 - Introducing Ida and Femtech03:41 - The Femtech Assembly Think Tank05:30 - Bridging the Gender Gap in Health Awareness07:20 - Involving Men in the Conversation11:12 - Founder Stories in Femtech Innovation

Hey listeners! Got plans for October 10th and 11th? Well, clear your calendars, because the FACTS About Fertility Virtual Conference is coming in hot and you won't want to miss it. Listen in today to Dr. Marguerite Duane and all the incredible work she is doing with FACTS, but also she is now the Director of the first ever Fertility Awareness Based Medical program in a medical school, Duquesne University! We're talking TWO days of inspiring talks, real connection, and expert insight—all from the comfort of your favorite sweatpants.

Curious about where women's health and femtech are headed? In this episode, Megan Swan welcomes Anna Butterworth, founder of Ultra Violet Agency, the world's first trend forecasting agency dedicated to women's health. Together, they illuminate how holistic foresight and technological innovation are reshaping the way we approach reproductive health, aging, femtech, and preventative wellness for women everywhere.Key Points Discussed:The Origin Story: Anna shares how her professional journey from marketing to femtech trailblazer was fueled by a personal awakening to the gaps in women's health education and resources.The Power of Strategic Foresight: How UltraViolet Agency predicts trends for the next decade, and why this matters for brands, investors, and consumers in the rapidly evolving femtech landscape.Beyond Point Solutions: The problem with industry fragmentation and the urgent need to solve women's health challenges on a strategic, global scale.Building Future-Proof Wellness: The methodology behind forecasting reports covering menopause, maternal care, women's sports, and more, including input from multidisciplinary experts and a focus on diversity and risk mitigation.Tech & Nature, Not Tech vs. Nature: Exploring the tension (and potential harmony) between technological innovation and environmental stewardship, with a forward-thinking look at how tech can empower rather than undermine women's health and the planet.Preventative & Personalized Care: Why the future of wellness is about actionable insights, hyper-personalization, and putting true agency back in women's hands without amplifying anxiety or bias.Healthy Aging and Menopause: Redefining aging for women, shifting from “lifespan” to “healthspan,” and supporting a new generation of women spending half their lives post-menopause.TLDR: Ultra Violet Agency is at the frontier of forecasting the next era in women's wellness, one that combines tech innovation, inclusivity, longevity, and women-first design to democratize health, prioritize prevention, and empower the next billion women.Thank you for listening!If this episode inspired you, take a screenshot and tag @meganswanwellness on social media.  Let's amplify the future of women's health together!Connect with Megan Swanhttp://www.instagram.com/meganswanwellnesshttp://www.linkedin.com/in/megan-swanwellnesswww.meganswanwellness.comLearn more about Anna Butterworth and UltraViolet Agency:https://www.ultraviolet.agency/reports*You can download the 2035 trend report!Keywordsfemtech, women's health forecasting, preventative care, personalized wellness, health data equity, trend reports, longevity, menopause, diversity in tech, gender health gap, holistic aging, future of healthcare, tech for good, environmentalism, social activism, female founders, digital wellness, inclusivity, reproductive health innovation, agency, healthspan, wellness strategy, lifestyle design.

In this episode, Dr. Stacy Sims dives into the latest advancements in women's health research, with a special focus on hormonal health, nutrition, and training strategies for women over 45. She breaks down why tracking menstrual cycles is key to understanding hormonal shifts, how restrictive diets can impact overall health, and why supplements like creatine and vitamin D are essential at this stage of life. Dr. Sims also highlights the importance of adapting training around perimenopause, incorporating strength work safely, and maintaining consistency while listening to your body. Beyond personal health, the conversation explores the growing FemTech movement, the push for more inclusive and women-centered research, and how to evaluate scientific claims with a critical lens. This episode offers practical strategies and fresh perspectives on women's health, performance, and longevity. https://goteamup.com/  https://www.podcastcollective.io/  

Today I'm honored to be joined by Ida Tin, founder of the Clue App, for a conversation all about redefining how we understand and approach women's health. Based in Berlin, Clue was one of the first mainstream apps designed specifically to help people understand their menstrual cycles - not just to predict periods, but to track fertility, PMS symptoms, mood energy levels, and more. We dive into the importance of cycle tracking as a wellness tool, how data can be used to reclaim agency over our health, and why designing tech specifically for the female body is long overdue. This is a conversation about purpose-driven entrepreneurship, getting in touch with our bodies, challenging the medical status quo, and building technology that actually gets us. Clue is offering With Whit listeners 90% off an annual subscription. Just use the code WITHWHIT at checkout on helloclue.comThis episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct, or indirect financial interest in products, or services referred to in this episodeProduced by Dear MediaSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Azin Radsan Van Alebeek is a co-founder and managing partner at Emmeline Ventures. This early-stage fund invests in and supports female-led start-ups in tech-enabled, FemTech, FinTech, and Sustainability sectors. With over 30 years of experience as an executive and board-level advisor, she leverages her strategic planning and coaching skills to help entrepreneurs scale their businesses, achieve their goals, and create returns for investors. Azin is passionate about empowering women to achieve financial sovereignty and make a positive impact in the world. She volunteers regularly to mentor other women on financial literacy, angel investing, and playing big.   In today's episode, Azin shares how an invitation to do something she knew little about led to betting on herself and ultimately becoming an investor in women's health, wealth, and overall well-being. Azin breaks down her role as Co-founder of Emmeline Ventures and the firm's focus on improving women's lives. She describes the meandering journey that took her career from consultant to PTA leadership to firm partner. Azin offers a digestible overview of venture capital, helping us identify who can benefit from VC support and who is better off without it. Check out Emmeline Venture's website and the resources Azin mentioned: I Relaunch, Golden Seeds, Portfolia, How Women Invest, and Show Her the Money. Follow on Instagram: @azinradvan. Please follow us at @thisislibertyroad on Instagram; we want to share and connect with you and hear your thoughts and comments. Please rate and review this podcast. It helps to know if these conversations inspire and equip you to consider your possibilities and lean into your future with intention.

Canadian born human rights lawyer, Stephanie Case, went viral online when she finished first place in the women's section of the Snowdonia ultra-trail 100km race despite giving birth six months ago and breastfeeding her daughter at aid stations. Stephanie tells Nuala McGovern about her first race as a mother and first competition in three years and why she chose to continue to do the things she loves after becoming a mum.In 2015, 22-year-old Alice Figueiredo took her own life whilst being treated at Goodmayes Hospital, east London. Over the course of her 5 month stay at the mental health unit she attempted suicide on 18 separate occasions. Following a seven-month trial at the Old Bailey, a jury found that not enough was done by the North East London Foundation NHS Trust, or ward manager Benjamin Aninakwa, to prevent Alice from killing herself. Alice's mum, Jane Figueiredo, has spent the last decade fighting to get the case to court. She discusses the impact it has had on her family.This week it was announced by Deloitte that the total revenues of Women's Super League (WSL) football clubs grew by 34 per cent to £65m in the 2023-24 season and are tipped to hit £100m for the first time next year. But while the four biggest-earning clubs generated most of the WSL revenue and the average WSL team's revenue increased there remains a yawning gap between the top and bottom teams. At the same time average attendances in the Women's Super League dropped by 10% last season compared with the previous campaign. To unpick this mixed picture we hear from Dr Christina Philippou, Associate Professor of Sports Finance at the University of Portsmouth.A new Cambridge University report published today calls on public health bodies like the NHS to offer apps that rival private FemTech services to prevent policing of reproductive choices. They are calling for better governance of the industry to protect users of cycle tracking apps (CTAs) when their data can be collected and sold at scale. Dr Stefanie Felsberger is lead author of The High Stakes of Tracking Menstruation.Presenter: Nuala McGovern Producer: Sarah Crawley

What if AI could finally solve one of the most overlooked challenges in women's health?Millions of women experience menopause, yet real support has always lagged behind, until now.In this episode of the 2B Bolder Podcast, I sit down with Susan Sly, tech founder, health advocate, and CEO of Pause AI, who is transforming how women navigate menopause through the use of artificial intelligence.Her journey is anything but traditional, from working on facial recognition algorithms in the '90s, to building a career in holistic health, to a life-threatening illness that nearly derailed everything. But that experience lit a fire—and brought her back to tech with a new mission: to build real-time, personalized solutions for the 1.1 billion women facing menopause.We talk about:The spark behind Pause AI at a Women in AI eventHow wearables and real-time data are changing the gameWhy only 2.5% of VC funding goes to women founders—and what she's doing anywayThe resilience it takes to walk away from what's working to build what's neededSusan gets real about leadership, aging, and why women should solve women's health issues.

Telehealth has exploded in the past few years as an accessible option for healthcare access. There are pitfalls, however. We talk about the good, the bad and the what to look out for, especially when it comes to women.See omnystudio.com/listener for privacy information.